Health Condition 1: F331- Major depressive disorder, recurrent, moderate
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr N Bhavana
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient willing to provide informed consent 2. Outpatients who are Newly diagnosed as depressive disorder and are on Antidepressants attending Psychiatry OPD 3. Age greater than 18years and both sexes
Exclusion criteria
Exclusion criteria: 1. Patients who are critically ill and suffering from Malignancies 2. Those who were judged clinically to be at a suicidal risk 3. Known cases of allergy to medications 4. Those who had a history of substance abuse 5. Patients who are previously diagnosed as chronic alcoholic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO assess the incidence, type and nature of adverse drug reaction associated with the use of Antidepressants in patients attending the Psychiatry OPDTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess sexual dysfunction in patients using antidepressants using the Arizona Sexual Experience Scale (ASEX). To assess the causality of reported ADRs using the WHO-UMC Causality Assessment Scale. To evaluate the pattern of antidepressant use (monotherapy vs combination therapy) and their association with ADRs. To observe laboratory changes (CBC, LFT, RFT, Lipid Profile, ECG) over time in relation to ADRs. To identify risk factors contributing to ADRs (e.g., demographic factors, comorbidities, polypharmacy).Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Nagesh H N
Shri Atal Bihari Vajpayee Medical College and Research Institute
Outcome results
None listed